Inthera Bioscience raised €3.5M in a Seed round in Dec 2015. The company is based in Zurich, Switzerland. Investors in the round: Aglaia Biomedical Ventures. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
